December 13
2:30 pm - 3:30 pm EST


Different approaches to process development and manufacturing in gene therapy

Gene therapy therapeutics development and manufacturing has a goal to treat disease by targeting the cause of the disease. Interest in gene therapy has continued to increase and the industry is evolving, but the design, development and scaling of manufacturing processes is complex and challenging.

In a panel discussion, co-sponsored by 3M, two industry experts discuss the strategies and opportunities for building next-generation gene therapy processes and new gene therapy manufacturing facilities. Learn more about the different approaches, in process development and manufacturing adopted along with the challenges, risks, and benefits.

  • Hear from industry leaders on their unique experience and approach to designing, building, and scaling a gene therapy processes.
  • Learn to build the next generation facility.
  • Learn about flexible manufacturing including new innovative single-use technology for harvest, clarification, and viral clearance.

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Andrew Tustian

Andrew Tustian

Director, Regeneron Pharmaceuticals, Inc.
Nripen Singh

Nripen Singh

Head of Process and Product Development, Passage Bio
Arsalan Arif

arsalan arif

Founder & Publisher, Endpoints News

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.